You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameRisperidoneProduct NameRISPERDAL®Therapeutic AreaBehaviors and Mental DisordersEnrollment330% FemaleN/A% WhiteN/A
Product ClassAtypical AntipsychoticsSponsor Protocol NumberRIS-USA-70 (EXTENSION OF RIS-USA-63) CR003361, RIS-USA-T216Data PartnerJohnson & JohnsonCondition StudiedDementiaMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0944 : Mediators of Mortality Risk in Older Adults with Dementia: Analysis of Multiple Pathways Using Risperidone Trial
- 2024-0492 : Predicting individual risks and benefits of antipsychotic treatment in people living with dementia
- 2022-4992 : Temporal trajectories of side-effects associated with antipsychotic treatment ? An individual participant data meta-analysis